[Etanercept in juvenile psoriasis].
Standard
[Etanercept in juvenile psoriasis]. / Beikert, Florian; Augustin, Matthias; Radtke, Marc.
in: HAUTARZT, Jahrgang 63, Nr. 5, 5, 2012, S. 406-410.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Beikert, F, Augustin, M & Radtke, M 2012, '[Etanercept in juvenile psoriasis].', HAUTARZT, Jg. 63, Nr. 5, 5, S. 406-410. <http://www.ncbi.nlm.nih.gov/pubmed/22573316?dopt=Citation>
APA
Beikert, F., Augustin, M., & Radtke, M. (2012). [Etanercept in juvenile psoriasis]. HAUTARZT, 63(5), 406-410. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22573316?dopt=Citation
Vancouver
Beikert F, Augustin M, Radtke M. [Etanercept in juvenile psoriasis]. HAUTARZT. 2012;63(5):406-410. 5.
Bibtex
@article{fa7e0fc0e4584a048fb3e40c680aa17e,
title = "[Etanercept in juvenile psoriasis].",
abstract = "With a prevalence of 0.71%, psoriasis represents one of the most frequent dermatoses in childhood.",
author = "Florian Beikert and Matthias Augustin and Marc Radtke",
year = "2012",
language = "Deutsch",
volume = "63",
pages = "406--410",
journal = "HAUTARZT",
issn = "0017-8470",
publisher = "Springer",
number = "5",
}
RIS
TY - JOUR
T1 - [Etanercept in juvenile psoriasis].
AU - Beikert, Florian
AU - Augustin, Matthias
AU - Radtke, Marc
PY - 2012
Y1 - 2012
N2 - With a prevalence of 0.71%, psoriasis represents one of the most frequent dermatoses in childhood.
AB - With a prevalence of 0.71%, psoriasis represents one of the most frequent dermatoses in childhood.
M3 - SCORING: Zeitschriftenaufsatz
VL - 63
SP - 406
EP - 410
JO - HAUTARZT
JF - HAUTARZT
SN - 0017-8470
IS - 5
M1 - 5
ER -
